Movicol and Pulmonary mass - a phase IV clinical study of FDA data

Summary:

Pulmonary mass is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are male, 60+ old, also take Pyridoxine, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Pulmonary mass when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Pulmonary mass?

Pulmonary mass is found to be associated with 1,137 drugs and 921 conditions by eHealthMe. Check the latest studies of Pulmonary mass.

On Aug, 11, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 13 people (0.09%) have Pulmonary mass.

Among these 13 people:

What is the gender of people who have Pulmonary mass when taking Movicol? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Pulmonary mass when taking Movicol? *

What are other drugs people take besides Movicol? *

Vitamin B12: 7 people, 53.85%
Pyridoxine: 7 people, 53.85%
Vitamin D: 6 people, 46.15%
Valium: 6 people, 46.15%
Avodart: 6 people, 46.15%
Azilect: 6 people, 46.15%
Panadol: 6 people, 46.15%
Omeprazole: 3 people, 23.08%
Folic Acid: 3 people, 23.08%
Paroxetine Hydrochloride: 2 people, 15.38%

What are other side effects people have besides Pulmonary mass? *

Back Pain: 6 people, 46.15%
Joint Pain: 6 people, 46.15%
Dyskinesia (abnormality or impairment of voluntary movement): 4 people, 30.77%
Pain In Extremity: 4 people, 30.77%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 23.08%
Leukoencephalopathy (disease of the white matter in the brain): 3 people, 23.08%
General Physical Health Deterioration (weak health status): 3 people, 23.08%
Weight Decreased: 3 people, 23.08%
C-Reactive Protein Increased: 3 people, 23.08%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 15.38%

What are the existing conditions these people have? *

Parkinson's Disease: 7 people, 53.85%
Pain: 5 people, 38.46%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 23.08%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
High Blood Cholesterol: 2 people, 15.38%
Heart Attack: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Pulmonary mass?

- Check whether Pulmonary mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Pulmonary mass treatments and more:

Pulmonary mass (17,472 reports)

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary mass:

Pulmonary mass (1,137 drugs)

Browse all the conditions that are associated with Pulmonary mass:

Pulmonary mass (921 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.